• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Does Methylphenidate Use in Children and Young Adults Increase Risk of Suicide?

Does Methylphenidate Use in Children and Young Adults Increase Risk of Suicide?

November 1, 2017
Arian Ayon Verduzco. Pharm.D candidate (2018)
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Arian Ayon Verduzco. Pharm.D candidate (2018) Ms. Verduzco has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Review Of: Man KKC et al, JAMA Psychiatry 2017;74(10):1048–1055

Some studies have indicated that patients with ADHD may be at an increased risk of suicide. While these studies have shown associations between methylphenidate use and suicide, it is not clear whether the stimulant actually causes suicidality or whether patients taking stimulants are suicidal for other reasons. This study sought to directly investigate a causal association.

This retrospective population-based case series study used data from a comprehensive patient reporting system in Hong Kong. In total, 25,629 patients aged 6–25 who had taken methylphenidate between January 2001 and December 2015 were identified. Of these patients, 154 of them had attempted suicide during the 15-year study period. In order to try to determine if methylphenidate was actually causing the suicidality, researchers zeroed in on the suicide attempt rate during three periods, or “risk windows,” as they called them: the pre-exposure period (90 days), the first 90 days of methylphenidate use, and any subsequent methylphenidate use.

Here’s what they found after their analysis. The chances of a suicide attempt were highest during the 90 days before the methylphenidate prescription (6.5-fold higher than baseline), and the risk dropped a little bit during the first 90 days of methylphenidate use down to a 4-fold risk. There was essentially no elevated suicide attempt risk observed with subsequent long-term methylphenidate use.

The authors conclude that the “most parsimonious interpretation of this pattern” is that methylphenidate use does not in itself increase the risk of suicide. Instead, the decision to start methylphenidate is preceded by a period of increased suicidal ideation, which gradually drops once the methylphenidate is started.

CCPR’s Take: When patients are considering starting a stimulant, they are going through difficult times, and it’s not surprising that the risk of a suicide attempt is high. We should feel comfortable medicating such patients with stimulants to treat their ADHD symptoms without the fear that the medication itself might aggravate suicidality.
Child Psychiatry
KEYWORDS adhd child-psychiatry research_updates
Arian Ayon Verduzco. Pharm.D candidate (2018)

More from this author
www.thecarlatreport.com
Issue Date: November 1, 2017
SUBSCRIBE NOW
Table Of Contents
CME Post-Test - Adolescents, CCPR, November/December 2017
Does Guanfacine Affect Tic Severity in Children With Chronic Tic Disorders?
Does Methylphenidate Use in Children and Young Adults Increase Risk of Suicide?
Tips on Managing Medications With Adolescents
Understanding Risk-Taking in Adolescents
DOWNLOAD NOW
Featured Book
  • CMFB2e_Cover.png

    Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

    All the important facts covering child and adolescent psychopharmacology.
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • teen_depression.jpeg
    Child Psychiatry

    Assessment of Non-Suicidal Self-Injury in Children and Adolescents

    Learn how to assess and intervene with NSSI, including ideas for supporting autonomy while addressing the behavior.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.